Table 1.
Characteristics of the study women (N = 635).
Figure 1.
Median CMV IgG (IU/mL) by HCV RNA status and age tertile in CMV-seropositive women (N = 594).
Table 2.
Median CMV IgG levels (IU/mL) stratified by HCV RNA status, age tertile, and HIV treatment status among CMV-seropositive women.
Table 3.
Independent associations of HCV RNA status and covariates with CMV IgG (IU/mL)a.